Background
Patients and methods
Study design and protocol
Participant selection
Setting
Eligibility criteria
Exclusion criteria
Follow-up
Outcome data, measures, and definitions
Patient demographics
Primary and secondary outcomes
Grouping criteria
Surgical procedure and postoperative treatment
Surgical procedure
-
① A fiber rope was threaded through the main surgical port to suspend the esophagus at the level of the azygos arch. The esophagus was drawn ventrally, revealing the trachea (Fig. 1b).
-
② The fascia in the tracheoesophageal groove was dissected along the left wall of the trachea, starting from the initial part of the left principal bronchus and extending to the uppermost part of the chest using an electric hook. Simultaneously, an assistant pushed the lower segment of the trachea and the left principal bronchus ventrally, ensuring complete exposure of the left RLN location (Fig. 1c). The left RLN was explored through blunt dissociation, and once exposed, a rubber band was placed around it for elastic suspension (Fig. 1d).
-
③ With forceps held in the left hand, the rubber band was elevated, thereby maintaining suspension of the left RLN. Utilizing the right hand, a blunt/sharp incision was made to expose the left RLN. Surrounding lymph nodes and tissues were dissected meticulously until reaching the inferior edge of the aortic arch and the base of the left pulmonary artery, ensuring a thorough dissection process.
-
④ Similar to step ③, the left RLN was completely exposed from the superior edge of the aortic arch. The surrounding lymph nodes and tissues were dissected until the cervical tissue (Fig. 1e). The inferior thyroid artery was the superior boundary of left RLN lymph node dissection.
-
⑤ From the level of aortic arch to cervical area, all lymph nodes and tissues were removed along the left RLN with an ultrasonic harmonic scalpel.
Postoperative treatment
Statistical analysis
Results
Patient characteristics and outcomes
Patient characteristics
ESLR group (n = 291) | Conventional group (n = 102) | P | |
---|---|---|---|
Age (years) | 60.79 ± 7.96 | 59.72 ± 8.80 | 0.253 |
Gender (n) | 0.211 | ||
male | 241(82.82%) | 90(88.24%) | |
female | 50(17.18%) | 12(11.76%) | |
Comorbidity (n) | |||
Hypertension | 105(36.08%) | 34(33.33%) | 0.633 |
Diabetes | 41(14.09%) | 12(11.76%) | 0.617 |
COPD | 32(11.00%) | 15(14.71%) | 0.375 |
Others | 21(7.22%) | 9(8.82%) | 0.665 |
Tumour locationa (n) | 0.728 | ||
Upper thoracic | 21(7.22%) | 5(4.91%) | |
Middle thoracic | 162(55.67%) | 59(57.84%) | |
Lower thoracic | 108(37.11%) | 38(37.25%) | |
Clinical stages (n) | 0.888 | ||
I | 43(14.78%) | 13(12.75%) | |
II | 187(64.26%) | 67(65.69%) | |
III | 61(20.96%) | 22(21.56%) | |
Neoadjuvant treatment (n) | 97(33.33%) | 30(29.41%) | 0.274 |
Surgeons (n) | 0.222 | ||
Doctor 1 | 105(36.08%) | 30(29.41%) | |
Doctor 2 | 186(63.92%) | 72(70.59%) |
Surgical outcomes of the patients
ESLR group (n = 291) | Conventional group (n = 102) | P | |
---|---|---|---|
Operative time (min) | 260.40 ± 26.49 | 255.25 ± 27.91 | 0.096 |
Chest | 61.43 ± 8.20 | 59.66 ± 8.51 | 0.064 |
Lymphadenectomy along left RLN | 11.85 ± 2.08 | 11.51 ± 1.57 | 0.091 |
Total number of LNs (n) | 32.71 ± 6.99 | 30.47 ± 6.87 | 0.005 |
Number of LNs along the left RLN (n) | 5.36 ± 1.35 | 3.07 ± 1.09 | < 0.001 |
Size of tumor (cm) | 3.54 ± 1.20 | 3.60 ± 1.12 | 0.666 |
Pathologic T stage (n) | 0.415 | ||
0 | 7(2.41%) | 3(2.94%) | |
1 | 45(15.46%) | 16(15.69%) | |
2 | 43(14.78%) | 22(21.57%) | |
3 | 196(67.35%) | 61(59.80%) | |
Pathologic N stage (n) | 0.426 | ||
0 | 139(47.77%) | 58(56.86%) | |
1 | 90(30.93%) | 28(27.45%) | |
2 | 45(15.46%) | 12(11.77%) | |
3 | 17(5.84%) | 4(3.92%) | |
Thoracic duct resection (n) | 0.957 | ||
Yes | 28(9.62%) | 10(9.80%) | |
N0 | 263(90.38%) | 92(90.20%) |
ESLR group (n = 291) | Conventional group (n = 102) | P | |
---|---|---|---|
Number of lymph nodes (n, 11th JES map) | |||
106recR | 3.10 ± 1.09 | 3.16 ± 1.18 | 0.676 |
106recL | 5.36 ± 1.35 | 3.07 ± 1.09 | < 0.001 |
Middle and lower mediastinum | 15.87 ± 15.26 | 15.13 ± 4.72 | 0.209 |
Enterocoelia | 8.37 ± 3.57 | 9.12 ± 4.27 | 0.085 |
Postoperative complications (n) | |||
RLN injury | 31 (10.65%) | 19 (18.63%) | 0.038 |
Pneumonia | 14 (4.81%) | 9 (8.82%) | 0.137 |
Anastomotic leakage | 17 (5.82%) | 7 (6.86%) | 0.711 |
Chyle leakage | 6 (2.05%) | 4 (3.92%) | 0.305 |
Others | 6 (2.05%) | 6 (5.88%) | 0.054 |
Overall survival of patients
Factors | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
Hazard ratio (95% CI) | P | Hazard ratio (95% CI) | P | |
Type of surgery | 0.002 | < 0.001 | ||
ESLR method | 0.744 (0.614–0.902) | 0.409 (0.274–0.612) | ||
Conventional method | 1(reference) | 1(reference) | ||
Age | 1.027 (1.002–1.052) | 0.034 | ||
Total number of harvested LNs | 0.973 (0.947–1.000) | 0.052 | ||
pT stage | 0.001 | 0.019 | ||
Tis | 0.135 (0.018–0.995) | 0.159 (0.021–1.203) | ||
T1 | 0.312 (0.158–0.615) | 0.403 (0.198–0.821) | ||
T2 | 0.718(0.433–1.191) | 0.596 (0.352–1.010) | ||
T3 | 1(reference) | 1(reference) | ||
pN stage | < 0.001 | 0.001 | ||
N0 | 0.350 (0.169–0.728) | 0.474 (0.225–0.997) | ||
N1 | 0.747 (0.362–1.540) | 1.023 (0.492–2.128) | ||
N2 | 0.922 (0.422–2.015) | 1.237 (0.562–2.724) | ||
N3 | 1(reference) | 1(reference) | ||
Number of harvested LNs along the left RLN | < 0.001 | < 0.001 | ||
1–2 | 1.886 (1.359–2.618) | 4.343 (2.420–7.794) | ||
3–5 | 1.066 (0.828–1.373) | 2.542 (1.635–3.951) | ||
6–7 | 1(reference) | 1(reference) | ||
Neoadjuvant treatment | 0.278 | |||
No | 1.261 (0.829–1.920) | |||
Yes | 1(reference) |